Medicotec have partnered with Bai Jerbai Wadia Hospital for Children in India for the first international feasibility study of their AI System with the aim of predicting the onset of sepsis in paediatric patients
2. Prescott et al https://www.atsjournals.org/doi/full/10.1164/rccm.201812-2383CP
4. Schlapback et al https://pubmed.ncbi.nlm.nih.gov/25471555/
PRESS RELEASE – DARWIN, AUSTRALIA 24 October 2022
Medicotec is an Australian MedTech start-up who are developing state-of-the-art technology systems to help doctors diagnose and manage serious health conditions. Medicotec have developed an Artificial Intelligence (AI) Clinical Decision Support system with the aim of identifying patients at risk of sepsis, whether they are in hospital, at home or at a remote clinic. The technology is now ready for clinical validation, so Medicotec are organising clinical trials and studies in hospitals around the world across a variety of medical specialties. The first study has been confirmed in Mumbai, India in December 2022.
Sepsis is a potentially life-threatening condition that occurs when the body’s response to an infection damages its own tissue. When the infection-fighting process turns on the body, they cause organs to function poorly and abnormally.
- 48.9 million cases globally
- 11 million deaths annually
- 1 in every 5 deaths worldwide are associated with sepsis
- 85% occur in low to middle income countries
- 2 out of every 5 cases are in children under 5
- Sepsis affects Australian First Nations adults at 4x the rate of Non-Indigenous Australian adults
- Sepsis affects Australian First Nations children at 7.7x the rate of Non-Indigenous Australian children
Prevention and early recognition of sepsis are of paramount importance as each hour’s delay in antibiotic administration results in an increased 7.6% risk of death. To date, there is no reliable early diagnostic test to identify sepsis. This is a global problem and Australia’s Medicotec is leading the way.
Medicotec have partnered with Bai Jerbai Wadia Hospital for Children in India for the first international feasibility study of their AI Algorithm with the aim of predicting the onset of sepsis in a paediatric hospital. A teaching hospital of world-wide repute, this 300-bed hospital is propelled by a highly accomplished team of over 60 paediatrics specialists devoting themselves to the care of over 100,000 children on an outpatient basis, and approximately 10,000 children as inpatients, annually. Located in the heart of Mumbai, The Bai Jerbai Wadia Hospital for Children pledges to extend its services to all people, regardless of their socio-economic status.
Joe Ward, CEO, Medicotec – “I am proud to announce a new international feasibility study by Medicotec in partnership with Bai Jerbai Wadia Hospital for Children which will utilize our AI technology to detect paediatric sepsis. This study marks a significant milestone for us, as we embark on our mission to improve healthcare outcomes for patients worldwide. Sepsis is a life-threatening condition that affects millions of people around the world, and its early detection is critical for ensuring timely treatment and a positive outcome. With the help of our state-of-the-art AI technology, we believe we can make a significant impact on the early detection of this devastating condition.”
Ward continued, “Our team of experts, including medical professionals and data scientists, have been working tirelessly to develop AI systems that can analyze vast amounts of patient data accurately and provide actionable insights to healthcare providers. By partnering with this leading paediatric hospital in India, we aim to enhance their diagnostic capabilities, improve patient outcomes, increase efficiency, and reduce healthcare costs. We are proud to be at the forefront of this evolution in healthcare, using technology to improve the lives of patients worldwide. We believe that this feasibility study will demonstrate the significant impact that Medicotec technology can have on healthcare outcomes, and we invite you to join us on this exciting journey as we work to tackle some of the world’s greatest health challenges.”
Sepsis in children is a significant cause of morbidity and mortality worldwide, over half of the global reported incidence of sepsis relates to the neonatal and paediatric population. World Health Organization statistics have shown that 80% of deaths in children <4 years can be classified as sepsis-related deaths. 26.4% of paediatric intensive care unit (PICU) deaths in Australia and New Zealand were related to severe infections such as sepsis and septic shock. The mortality rate of sepsis in children from paediatric intensive care units of developing countries is higher than 50%. It is estimated that up to one third of children who survive sepsis are left with significant morbidity including amputations, cognitive impairment and other, sometimes life-long conditions which will affect their quality of life.
Dr Minnie Bodhanwala, CEO, Bai Jerbai Wadia Hospital for Children – “We at Bai Jerbai Wadia Hospital for Children, Mumbai, are happy to collaborate with the Medicotec team for the study to develop an algorithm that can predict the occurrence of sepsis in children. Sepsis in our subcontinent is rampant and spreads more rapidly in neonates & young infants, thereby increasing their morbidity and mortality significantly. If proven to be effective, this algorithm could enable our doctors to diagnose sepsis early-on and start appropriate therapy at an optimal time in the admitted patients. These patients are mainly from the underprivileged economic strata of the society. Early diagnosis could additionally help decrease wastage of precious resources like medicines (inotropes, antibiotics), decrease ICU transfers and prevent development of antibiotic resistance (which is a major issue these days). This algorithm could also help decrease the financial burden of the parents of these sick children substantially as most of them are still devoid of insurance and pay out-of-pocket. We are eagerly awaiting the study and the AI system to be incorporated in our institution, as we house one of the largest NICU facilities in the country.”
Authorised for release by Medicotec’s Board of Directors.